Literature DB >> 21745723

Hippocampal interneurons are abnormal in schizophrenia.

Christine Konradi1, C Kevin Yang, Eric I Zimmerman, Kathryn M Lohmann, Paul Gresch, Harry Pantazopoulos, Sabina Berretta, Stephan Heckers.   

Abstract

OBJECTIVE: The cellular substrate of hippocampal dysfunction in schizophrenia remains unknown. We tested the hypothesis that hippocampal interneurons are abnormal in schizophrenia, but that the total number of hippocampal neurons in the pyramidal cell layer is normal.
METHODS: We collected whole hippocampal specimens of 13 subjects with schizophrenia and 20 matched healthy control subjects to study the number of all neurons, the somal volume of neurons, the number of somatostatin- and parvalbumin-positive interneurons and the messenger RNA levels of somatostatin, parvalbumin and glutamic acid decarboxylase 67.
RESULTS: The total number of hippocampal neurons in the pyramidal cell layer was normal in schizophrenia, but the number of somatostatin- and parvalbumin-positive interneurons, and the level of somatostatin, parvalbumin and glutamic acid decarboxylase mRNA expression were reduced.
CONCLUSIONS: The study provides strong evidence for a specific defect of hippocampal interneurons in schizophrenia and has implications for emerging models of hippocampal dysfunction in schizophrenia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745723      PMCID: PMC3159834          DOI: 10.1016/j.schres.2011.06.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  45 in total

Review 1.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  Hippocampal interneurons in bipolar disorder.

Authors:  Christine Konradi; Eric I Zimmerman; C Kevin Yang; Kathryn M Lohmann; Paul Gresch; Harry Pantazopoulos; Sabina Berretta; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2010-12-06

3.  Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.

Authors:  Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

4.  Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression.

Authors:  R E Straub; B K Lipska; M F Egan; T E Goldberg; J H Callicott; M B Mayhew; R K Vakkalanka; B S Kolachana; J E Kleinman; D R Weinberger
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

Review 5.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

6.  Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain.

Authors:  Xin Duan; Jay H Chang; Shaoyu Ge; Regina L Faulkner; Ju Young Kim; Yasuji Kitabatake; Xiao-bo Liu; Chih-Hao Yang; J Dedrick Jordan; Dengke K Ma; Cindy Y Liu; Sundar Ganesan; Hwai-Jong Cheng; Guo-li Ming; Bai Lu; Hongjun Song
Journal:  Cell       Date:  2007-09-06       Impact factor: 41.582

7.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

8.  Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; John P Walsh; Sivan Subburaju; Martin Minns
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

9.  A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Margarita M Behrens; Anthony A Grace
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

Review 10.  Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies.

Authors:  David A Lewis; Robert A Sweet
Journal:  J Clin Invest       Date:  2009-04-01       Impact factor: 14.808

View more
  128 in total

1.  Gestational methylazoxymethanol acetate administration alters proteomic and metabolomic markers of hippocampal glutamatergic transmission.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

2.  Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region.

Authors:  Alice Y Wang; Kathryn M Lohmann; C Kevin Yang; Eric I Zimmerman; Harry Pantazopoulos; Nicole Herring; Sabina Berretta; Stephan Heckers; Christine Konradi
Journal:  Acta Neuropathol       Date:  2011-10-04       Impact factor: 17.088

3.  Hippocampus at 25.

Authors:  Howard Eichenbaum; David G Amaral; Elizabeth A Buffalo; György Buzsáki; Neal Cohen; Lila Davachi; Loren Frank; Stephan Heckers; Richard G M Morris; Edvard I Moser; Lynn Nadel; John O'Keefe; Alison Preston; Charan Ranganath; Alcino Silva; Menno Witter
Journal:  Hippocampus       Date:  2016-07-29       Impact factor: 3.899

4.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

5.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

6.  Relational memory and hippocampal function in psychotic bipolar disorder.

Authors:  Suzanne N Avery; Lisa E Williams; Austin A Woolard; Stephan Heckers
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-11       Impact factor: 5.270

7.  ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity.

Authors:  Robert M Mitchell; Megan J Janssen; Irina Karavanova; Detlef Vullhorst; Katrina Furth; Anthony Makusky; Sanford P Markey; Andres Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

8.  Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Authors:  Philip L R Gaskin; Stephen P H Alexander; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

9.  An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.

Authors:  Li Chen; Stephanie M Perez; Daniel J Lodge
Journal:  Dev Neurobiol       Date:  2014-03-03       Impact factor: 3.964

10.  Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure.

Authors:  Katharina Klinger; Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Eur Neuropsychopharmacol       Date:  2019-07-29       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.